Yes, IRBT needs/could use SOMETHING (aren't all companies supposed to try and MAXIMIZE shareholder value?), they are UNFAIRLY undervalued. EITHER existing management figures that out, and how to address, or they will eventually be GONE (management that is). JUST STATING A FACT with regard to how the world works. There is TREMENDOUS value in IRBT that is not being seen and NEEDS to be unlocked. No offense if you are existing management, I believe the team has done a great job (with the exception of addressing the medical/medical device market place) and getting the investment world to SEE THE TRUE VALUE. If this team can't DO it, they will be replaced, or find themselves at the nasty end of a smart acquirer, that sees the potential and KNOWS how to develop/attain. I love IRBT and have been, and will continue to be a LONG TERM INVESTOR (been here since April of 2007, so have ridden it down, and now back up). I just believe their is GREAT opportunity in the medical market place, and BB could be a foot in the door.